These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33828444)

  • 1. A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma.
    Ferrari B; Roda E; Priori EC; De Luca F; Facoetti A; Ravera M; Brandalise F; Locatelli CA; Rossi P; Bottone MG
    Front Neurosci; 2021; 15():589906. PubMed ID: 33828444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells.
    Ferrari B; Urselli F; Gilodi M; Camuso S; Priori EC; Rangone B; Ravera M; Veneroni P; Zanellato I; Roda E; Osella D; Bottone MG
    Neurotox Res; 2020 Jan; 37(1):183-197. PubMed ID: 31240667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme.
    Gaiaschi L; Roda E; Favaron C; Gola F; Gabano E; Ravera M; Rossi P; Bottone MG
    Biomed Pharmacother; 2022 Nov; 155():113729. PubMed ID: 36166961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new platinum-based prodrug candidate: Its anticancer effects in B50 neuroblastoma rat cells.
    Rangone B; Ferrari B; Astesana V; Masiello I; Veneroni P; Zanellato I; Osella D; Bottone MG
    Life Sci; 2018 Oct; 210():166-176. PubMed ID: 30144454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.
    Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D
    Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the activation of cell death mechanisms: in search of new therapeutic targets in glioblastoma multiforme.
    Gaiaschi L; Favaron C; Casali C; Gola F; De Luca F; Ravera M; Roda E; Rossi P; Bottone MG
    Apoptosis; 2023 Aug; 28(7-8):1241-1257. PubMed ID: 37244884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound.
    Favaron C; Gaiaschi L; Casali C; De Luca F; Gola F; Cavallo M; Ramundo V; Aldieri E; Milanesi G; Visonà SD; Ravera M; Bottone MG
    Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer.
    Sabbatini M; Zanellato I; Ravera M; Gabano E; Perin E; Rangone B; Osella D
    J Med Chem; 2019 Apr; 62(7):3395-3406. PubMed ID: 30879295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma.
    Jimenez-Macias JL; Lee YC; Miller E; Finkelberg T; Zdioruk M; Berger G; Farquhar CE; Nowicki MO; Cho CF; Fedeles BI; Loas A; Pentelute BL; Lawler SE
    J Control Release; 2022 Dec; 352():623-636. PubMed ID: 36349615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy.
    Zheng S; Li G; Shi J; Liu X; Li M; He Z; Tian C; Kamei KI
    J Control Release; 2023 Sep; 361():819-846. PubMed ID: 37597809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MP-Pt(IV): A MAOB-Sensitive Mitochondrial-Specific Prodrug for Treating Glioblastoma.
    Raghavan S; Baskin DS; Sharpe MA
    Mol Cancer Ther; 2020 Dec; 19(12):2445-2453. PubMed ID: 33033175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.
    Yao H; Chen S; Deng Z; Tse MK; Matsuda Y; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11823-11833. PubMed ID: 32799491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-functional biotinylated platinum(IV)-SAHA conjugate for tumor-targeted chemotherapy.
    Gupta A; Sasmal PK
    Dalton Trans; 2024 Nov; 53(44):17829-17840. PubMed ID: 39404606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates.
    Novohradsky V; Zanellato I; Marzano C; Pracharova J; Kasparkova J; Gibson D; Gandin V; Osella D; Brabec V
    Sci Rep; 2017 Jun; 7(1):3751. PubMed ID: 28623355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
    Braga CB; Perli G; Becher TB; Ornelas C
    Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.
    Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
    Biochem Pharmacol; 2015 Jun; 95(3):133-44. PubMed ID: 25888926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells.
    Alessio M; Zanellato I; Bonarrigo I; Gabano E; Ravera M; Osella D
    J Inorg Biochem; 2013 Dec; 129():52-7. PubMed ID: 24080480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway.
    Aroui S; Dardevet L; Ben Ajmia W; de Boisvilliers M; Perrin F; Laajimi A; Boumendjel A; Kenani A; Muller JM; De Waard M
    Mol Pharm; 2015 Dec; 12(12):4336-48. PubMed ID: 26465677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
    Alfonso-Triguero P; Lorenzo J; Candiota AP; Arús C; Ruiz-Molina D; Novio F
    Nanomaterials (Basel); 2023 May; 13(10):. PubMed ID: 37242036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
    Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S
    BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.